ArticleAnnals of medicine2026
Connective tissue disease-associated interstitial lung disease: immune profiling and correlation of immune cells with pulmonary function in SSc-ILD.
Article in Annals of medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundConnective tissue diseases (CTDs) frequently involve the lungs, with CTD-associated interstitial lung disease (CTD-ILD) representing a leading cause of morbidity and mortality, yet the immunopathological mechanisms remain incompletely defined. This study characterized immune profiles in CTD-ILD and their association with pulmonary function impairment, focusing on systemic sclerosis-associated ILD (SSc-ILD).
methodsThis single-center retrospective study enrolled 217 CTD-ILD patients, 100 healthy controls, and 25 idiopathic pulmonary fibrosis (IPF) patients. Peripheral lymphocyte subsets, immunoglobulins, complements, and cytokines were assessed using flow cytometry and immunoturbidimetry. Lung function was evaluated by standard spirometry and gas transfer tests.
resultsCompared to healthy controls, lymphocyte counts were reduced in all ILD subtypes, lowest in polymyositis/dermatomyositis (PM/DM)-ILD. In SSc-ILD, T cell and helper T cell (Th) percentages were significantly elevated (76.2% and 49.39%, respectively). Complement C3 was lower in Sjögren's syndrome (SS)-ILD (889.92 vs. 965.49 mg/L), and C4 was significantly lower in SSc-ILD (196.74 vs. 226.70 mg/L) versus controls. SSc-ILD patients with higher Th cell proportions exhibited worse pulmonary function, with expiratory reserve volume (ERV) falling 57.21%, maximal vital capacity (VC max) 18.81%, functional residual capacity (FRC) 19.64%, forced vital capacity (FVC)17.93%, and diffusing capacity for carbon monoxide (DLCO) 20.28%. Continuous correlation analysis further confirmed significant negative correlations between Th cell proportions and ERV, FRC, and PCO
conclusionPeripheral blood immune profiling revealed distinct abnormalities across CTD-ILD subtypes. Peripheral Th cell expansion is strongly associated with lung function decline in SSc-ILD, highlighting the potential of Th cells as biomarkers of disease progression in SSc-ILD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.